AWM
PCRX icon

AllSquare Wealth Management’s Pacira BioSciences PCRX Stock Holding History

AllSquare Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26
Closed -$1K – 484
2020
Q1 		$1K Hold
26
– – ﹤0.01% 435
2019
Q4 		$1K Hold
26
– – ﹤0.01% 439
2019
Q3 		$1K Hold
26
– – ﹤0.01% 442
2019
Q2 		$1K Buy
+26
New +$1.1K ﹤0.01% 447

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

AllSquare Wealth Management's PCRX Position: Q2 2020 in Review

AllSquare Wealth Management sold out of Pacira BioSciences (PCRX) in Q2 2020, closing a stake of 26 shares — an estimated $1K sold.

AllSquare Wealth Management first reported a position in PCRX in Q2 2019 and held it in 4 quarters. The position peaked at $1K in Q1 2020. 248 funds tracked by Wall St. Rank hold PCRX as of Q2 2020.

  • AllSquare Wealth Management reported no remaining Pacira BioSciences position as of Q2 2020 after selling out during the quarter.
  • AllSquare Wealth Management sold 26 Pacira BioSciences shares in Q2 2020, an estimated $1K.
  • AllSquare Wealth Management first reported a position in Pacira BioSciences in Q2 2019 and held it in 4 quarters.
  • AllSquare Wealth Management's Pacira BioSciences position peaked at $1K in Q1 2020.
  • 248 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2020.

Based on AllSquare Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.